Is tailored adjuvant treatment for colon cancer possible?

Van den Eynde, Marc;Awada, Ahmad;Hendlisz, Alain
(2010) Clinical Colorectal Cancer — Vol. 9, p. 15-21 (2010)

Files

2010_van_den_Eynde_Clin_Colorectal_Cancer.pdf
  • Restricted Access
  • Adobe PDF
  • 107.54 KB
Request a copy

Details

Authors
Abstract
High-risk stage II and stage III colon cancers are associated with significant recurrence rates after surgical resection. Adjuvant chemotherapy has demonstrated a significant disease-free and overall survival benefit for patients, even if not helpful for all. Currently, there are limited clinical and molecular markers that can predict response to chemotherapy and clinical outcome in advanced colon cancer. Herein, we review and discuss recent data about the most promising clinicopathologic and molecular factors described thus far and that are of interest in the management of patients with colon cancer.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Van den Eynde, M., Awada, A., & Hendlisz, A. (2010). Is tailored adjuvant treatment for colon cancer possible? Clinical Colorectal Cancer, 9, 15-21. https://doi.org/10.3816/CCC.2010.n.002 (Original work published 2010)